Elbit Medical Technologies Ltd (EMTC-M.TA)

ILA 16.1

(6.62%)

Market Cap (In ILA)

14.6 Million

Revenue (In ILA)

271 Thousand

Net Income (In ILA)

-17.79 Million

Avg. Volume

20.59 Thousand

Currency
ILA
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.12-16.1
PE
-
EPS
-
Beta Value
0.207
ISIN
IL0004740150
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Ron Hadassi BA, LL.B, MBA
Employee Count
-
Website
-
Ipo Date
2010-11-28
Details
Elbit Medical Technologies Ltd, an investment holding company, engages in the research, development, production, and marketing of therapeutic medical systems in the United States, Europe, and internationally. The company is developing a magnetic resonance imaging guided focused ultrasound treatment equipment to address various oncology and gynecology indications, as well as neurological disorders and tumors. It is also involved in the study and development of medical products based on stem cells originating primarily from the umbilical cord blood that are used for bone marrow transplants in the patients of leukemia or cancer of lymph nodes, non-malignant blood diseases, and metabolic genetic disorders. The company is based in Petah Tikva, Israel. Elbit Medical Technologies Ltd is a subsidiary of Exigent Management Ltd.